https://www.rcsb.org/structure/4I21
RCSB PDB - 4I21: Crystal structure of L858R + T790M EGFR kinase domain in complex with MIG6 peptide
Crystal structure of L858R + T790M EGFR kinase domain in complex with MIG6 peptide
https://www.spandidos-publications.com/10.3892/ol.2014.2321?text=fulltext
Lung adenocarcinoma harboring L858R and T790M mutations in epidermal growth factor receptor, with...
Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.
https://www.ncbi.nlm.nih.gov/Structure/pdb/7JXM
7JXM: EGFR kinase (T790M/V948R) in complex with osimertinib and EAI045
Epidermal growth factor receptor(2R)-2-(5-fluoro-2-hydroxyphenyl)-2-(1-oxo-1,3-dihydro-2H-isoindol-2-yl)-N-(1,3-thiazol-2-yl)acetamideMAGNESIUM...
egfrkinaset790m
https://www.rcsb.org/structure/4WD5
RCSB PDB - 4WD5: Crystal structure of EGFR 696-1022 T790M in complex with QL-X138
Crystal structure of EGFR 696-1022 T790M in complex with QL-X138
https://www.semanticscholar.org/topic/EGFR-T790M-Inhibitor-PF-06747775/2727832
EGFR T790M Inhibitor PF-06747775 | Semantic Scholar
An orally available inhibitor of the epidermal growth factor receptor (EGFR) mutant form T790M, with potential antineoplastic activity. EGFR T790M inhibitor...
egfrt790minhibitorpfsemantic
https://www.ncbi.nlm.nih.gov/Structure/pdb/4G5P
4G5P: Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992
EPIDERMAL GROWTH FACTOR RECEPTORAfatinib, Bound...
crystal structureegfr
https://www.rcsb.org/structure/5HG9
RCSB PDB - 5HG9: EGFR (L858R, T790M, V948R) in complex with...
EGFR (L858R, T790M, V948R) in complex with...
rcsb pdbegfrt790mcomplex
https://www.rcsb.org/structure/5EDQ
RCSB PDB - 5EDQ: EGFR kinase (T790M/L858R) with inhibitor compound 15:...
EGFR kinase (T790M/L858R) with inhibitor compound 15:...
rcsb pdbegfrkinase
https://www.ncbi.nlm.nih.gov/Structure/pdb/6JRX
6JRX: EGFR T790M/C797S in complex with compound 6i
Epidermal growth factor...
egfrt790mcomplexcompound6i
https://www.nice.org.uk/guidance/ta653/informationforpublic
Information for the public | Osimertinib for treating EGFR T790M mutation-positive advanced...
Evidence-based recommendations on osimertinib (Tagrisso) for treating epidermal growth factor receptor (EGFR) T790M mutation-positive locally advanced or...
information for the publicosimertinib